Advertisement

Topics

Kirin Brewery Co.,LTD Company Profile

05:14 EDT 22nd September 2018 | BioPortfolio

Nil

Location

2-10-1 Shinkawa
Tokyo
Chuo-ku
104-8288
Japan

Contact

Phone: 03(5540)3411
Fax: 03(5540)3547


News Articles [80 Associated News Articles listed on BioPortfolio]

Kyowa Kirin gibt positive Stellungnahme des CHMP zu Mogamulizumab zur Behandlung von Mycosis fungoides und Sézary-Syndrom bekannt

Tokio (ots/PRNewswire) - Mogamulizumab wäre nach Zulassung der erste biologische Wirkstoff gegen CCR4 für Patienten in Europa. Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin), hat heute bekanntgegeben, ....

20152023 World Fruit Beers Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 19022018] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and en...

Kyowa Hakko Kirin Announces FDA Notification of PDUFA Action Date Extension for Mogamulizumab

Tokyo, Japan, May 30, 2018 –Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151 President and COO: Masashi Miyamoto, “Kyowa Hakko Kirin”) announced today that it has been notified that the U.S. Food and Dr...

Crysvita Meets Primary Endpoint in Phase 3 Trial in Children with X-Linked Hypophosphatemia

NOVATO, Calif. and TOKYO and LONDON, May 17, 2018 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products fo...

FDA Approves Crysvita, The First Therapy for X-Linked Hypophosphatemia, A Rare Inherited Form of Rickets

NOVATO, Calif. and TOKYO and LONDON, April 17, 2018 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel produ...

Fujifilm Kyowa Kirin Biologics arbeitet mit Mylan zusammen an Vermarktung von Biosimilar zu Humira (Adalimumab)

Fujifilm Kyowa Kirin Biologics Co. Ltd. gab heute bekannt, dass das Unternehmen mit Mylan N.V. (NASDAQ:MYL) zusammenarbeiten wird, um FKB327, ein von Fujifilm Kyowa Kirin Biologics entwickeltes Bi...

FDA Approves Kyowa Kirin’s Poteligeo for Treatment of Two Rare Types of Non-Hodgkin Lymphoma

TOKYO, Aug. 8, 2018 /PRNewswire/ — Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces today that the U.S. Food and Drug Administration (FDA) has granted approval for Poteligeo® (mogamulizumab...

FDA approves Kyowa Kirin’s Poteligeo to treat two lymphoma types

The US Food and Drug Administration (FDA) has granted approval to biotechnology company Kyowa Kirin’s Poteligeo (mogamulizumab-kpkc) injection to treat...Read More... The post FDA approves Kyowa...

Drugs and Medications [0 Results]

None

PubMed Articles [11 Associated PubMed Articles listed on BioPortfolio]

Microwave-assisted one-pot conversion of agro-industrial wastes into levulinic acid: An alternate approach.

Brewery liquid waste (BLW), brewery spent grain (BSG), apple pomace solid wastes (APS), apple pomace ultrafiltration sludge (APUS) and starch industry waste (SIW) were evaluated as alternative feedsto...

Combining biotechnology with circular bioeconomy: From poultry, swine, cattle, brewery, dairy and urban wastewaters to biohydrogen.

The ability of microalgae to grow in nutrient-rich environments and to accumulate nutrients from wastewaters (WW) makes them attractive for the sustainable and low-cost treatment of WW. The valuable b...

The Student t-test is a beer test.

The Student-t-test, one of the most used statistical tests in medicine, was developed by a beer brewer. From around 1900, the Irish Guinness brewery started recruiting scientists for the position of b...

Competitive inter-species interactions underlie the increased antimicrobial tolerance in multispecies brewery biofilms.

Genetic diversity often enhances the tolerance of microbial communities against antimicrobial treatment. However the sociobiology underlying this antimicrobial tolerance remains largely unexplored. He...

Brewery wastewater treatment and resource recovery through long term continuous-mode operation in pilot photosynthetic bacteria-membrane bioreactor.

Photosynthetic bacteria (PSB) are considered ideal for high COD wastewater treatment and resource recovery. This work is the first continuous-mode long-term (440 days) pilot study (240 L) by using...

Clinical Trials [0 Results]

None

Companies [17 Associated Companies listed on BioPortfolio]

Kirin Brewery Co.,LTD

Nil

Kirin Brewery Company Limited

Drug Discovery

Hematech, Inc.

Hematech, LLC was founded in 1998 and has its corporate headquarters in Sioux Falls, SD. In 1999, Hematech and the Pharmaceutical Division of the Kirin Brewery Company began a research collaboration t...

Kyowa Hakko Kirin Co. Ltd.

Kyowa Hakko Kirin Co., Ltd.

More Information about "Kirin Brewery Co.,LTD" on BioPortfolio

We have published hundreds of Kirin Brewery Co.,LTD news stories on BioPortfolio along with dozens of Kirin Brewery Co.,LTD Clinical Trials and PubMed Articles about Kirin Brewery Co.,LTD for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kirin Brewery Co.,LTD Companies in our database. You can also find out about relevant Kirin Brewery Co.,LTD Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record